CPT breakdown within procedure type: (**double check 45395 should fall under RPC IPAA and not TAC EI, have it under TAC EI for now**)
Procedure Type
CPT
Procedure
RPC IPAA
44157
Colectomy, total, abdominal, with proctectomy; with ileoanal anastomosis, includes loop ileostomy, and rectal mucosectomy, when performed
44158
Colectomy, total, abdominal, with proctectomy; with ileoanal anastomosis, creation of ileal reservoir (S or J), includes loop ileostomy, and rectal mucosectomy, when performed
44211
Laparoscopy, surgical; colectomy, total, abdominal, with proctectomy, with ileoanal anastomosis, creation of ileal reservoir (S or J), with loop ileostomy, includes rectal mucosectomy, when performed
45113
Proctectomy, partial, with rectal mucosectomy, ileoanal anastomosis, creation of ileal reservoir (S or J), with or without loop ileostomy
45397
Laparoscopy, surgical; proctectomy, combined abdominoperineal pull-through procedure (eg, colo-anal anastomosis), with creation of colonic reservoir (eg, J-pouch), with diverting enterostomy, when performed
TAC EI
44150
Colectomy, total, abdominal, without proctectomy; with ileostomy or ileoproctostomy
44151
Colectomy, total, abdominal, without proctectomy; with continent ileostomy
44210
Laparoscopy, surgical; colectomy, total, abdominal, without proctectomy, with ileostomy or ileoproctostomy
TPC EI/Non restorative proctectomy
44156
Colectomy, total, abdominal, with proctectomy; with continent ileostomy
44212
Laparoscopy, surgical; colectomy, total, abdominal, with proctectomy, with ileostomy
44155
Colectomy, total, abdominal, with proctectomy; with ileostomy
45395
Laparoscopy, surgical; proctectomy, complete, combined abdominoperineal, with colostomy
4. Ileostomy Formation Variable
Using variable ileostomy_formation to see further information on ileostomy. Have several answer choices for this: conversion of end to loop, ibd_ileost, ileostomy from prior is unaltered, new ileostomy, new stoma, none, other ileostomy revision, n/a
Conversion of end ileostomy to loop ibd_ileost
563 27
Ileostomy from prior is unaltered New ileostomy
113 1446
New stoma None
1 51
Other ileostomy revision <NA>
47 252
5. Defining Staged Procedures
First look at breakdown of how ileostomy_formation is coded against CPT codes
Definitions
1-Stage RPC-IPAA (Proctocolectomy + IPAA without diverting ileostomy):
CPT: Total proctocolectomy with IPAA (44157, 44158, 44211).
ileostomy_formation: "none"(no loop ileostomy at the time of pouch creation)
2-Stage RPC-IPAA (Proctocolectomy + IPAA with diverting loop ileostomy):
CPT: Total proctocolectomy with IPAA (44157, 44158, 44211).
ileostomy_formation: "new ileostomy" or "new stoma"(Stage 1 of a 2-stage procedure; Stage 2 is the later ileostomy reversal)
3-Stage Approach -> Stage 1 (Subtotal/Total Abdominal Colectomy with End Ileostomy, TAC-EI):
CPT:44150, 44151, 44210.
ileostomy_formation: "new ileostomy" or "new stoma". (patient undergoing TAC-EI is starting either a 3-stage or a modified 2-stage pathway. In single-encounter NSQIP data, TAC-EI represents the initial staged colectomy)
CPT: Completion proctectomy with IPAA (45113, 45397).
ileostomy_formation: "none"(prior end ileostomy taken down and anastomosed the pouch without creating a new diverting stoma)
Non-Restorative Surgery (Total Proctocolectomy with Permanent End Ileostomy, TPC-EI):
CPT:44155, 44156, 44212, or 45395 (APR with colostomy).
assumed not a staged IPAA- have permanent end ileostomy or colostomy
Visual Diagram of Procedure Breakdown
flowchart TD
Start["<b>NSQIP IBD Surgical Cohort</b><br/>Classify by Primary CPT & ileostomy_formation"] --> CPT1["<b>Total Proctocolectomy + IPAA</b><br/>CPT: 44157, 44158, 44211"]
Start --> CPT2["<b>Subtotal / Total Colectomy</b><br/>CPT: 44150, 44151, 44210"]
Start --> CPT3["<b>Completion Proctectomy + IPAA</b><br/>CPT: 45113, 45397"]
Start --> CPT4["<b>Total Proctocolectomy / APR</b><br/>CPT: 44155, 44156, 44212, 45395"]
CPT1 --> Ileo1A{"ileostomy_formation"}
Ileo1A -- "'none'" --> Out1["<b>1-Stage RPC-IPAA</b><br/>Proctocolectomy + IPAA<br/><i>No diverting loop ileostomy</i>"]
Ileo1A -- "'new ileostomy' /<br/>'new stoma'" --> Out2["<b>2-Stage RPC-IPAA (Stage 1)</b><br/>Proctocolectomy + IPAA<br/><i>With diverting loop ileostomy</i>"]
CPT2 --> Ileo2{"ileostomy_formation"}
Ileo2 -- "'new ileostomy' /<br/>'new stoma'" --> Out3["<b>3-Stage or Modified 2-Stage (Stage 1)</b><br/>TAC-EI: Initial staged colectomy<br/><i>With end ileostomy</i>"]
CPT3 --> Ileo3{"ileostomy_formation"}
Ileo3 -- "'conversion of end to loop' /<br/>'new ileostomy' / 'unaltered'" --> Out4["<b>3-Stage Approach (Stage 2)</b><br/>Completion Proctectomy + IPAA<br/><i>With diverting loop ileostomy</i>"]
Ileo3 -- "'none'" --> Out5["<b>Modified 2-Stage (Stage 2)</b><br/>Completion Proctectomy + IPAA<br/><i>End ileostomy taken down; no diversion</i>"]
CPT4 --> Out6["<b>Non-Restorative Surgery (TPC-EI)</b><br/>Permanent end ileostomy or colostomy<br/><i>Not a staged IPAA pathway</i>"]
classDef cpt fill:#e8f1f8,stroke:#2b6cb0,stroke-width:1.5px,color:#1a202c
classDef restorative fill:#e6fffa,stroke:#2c7a7b,stroke-width:1.5px,color:#1a202c
classDef nonrestorative fill:#fff5f5,stroke:#c53030,stroke-width:1.5px,color:#1a202c
class CPT1,CPT2,CPT3,CPT4 cpt
class Out1,Out2,Out3,Out4,Out5 restorative
class Out6 nonrestorative
Characteristic
level
Overall
White
URM
Asian
p
test
n
2281
1954
277
50
Age at surgery, years (mean (SD))
42.85 (16.87)
43.21 (16.99)
40.36 (15.85)
42.49 (16.64)
0.030
Sex (%)
Female
631 (44.5)
540 (44.0)
80 (51.9)
11 (31.4)
0.049
Male
786 (55.5)
688 (56.0)
74 (48.1)
24 (68.6)
BMI, kg/m² (mean (SD))
25.42 (5.75)
25.37 (5.54)
26.27 (7.07)
22.71 (4.80)
<0.001
Diabetes mellitus (%)
Insulin
65 (2.8)
49 (2.5)
12 (4.3)
4 (8.0)
0.058
No
2140 (93.8)
1837 (94.0)
259 (93.5)
44 (88.0)
Non-Insulin
76 (3.3)
68 (3.5)
6 (2.2)
2 (4.0)
Hypertension requiring medication (%)
No
1920 (84.2)
1640 (83.9)
240 (86.6)
40 (80.0)
0.366
Yes
361 (15.8)
314 (16.1)
37 (13.4)
10 (20.0)
Current smoker (within 1 year) (%)
No
2150 (94.3)
1842 (94.3)
259 (93.5)
49 (98.0)
0.452
Yes
131 (5.7)
112 (5.7)
18 (6.5)
1 (2.0)
ASA classification (%)
ASA 1 - No Disturb
8 (0.4)
7 (0.4)
1 (0.4)
0 (0.0)
0.002
ASA 2 - Mild Disturb
1127 (49.4)
976 (49.9)
130 (46.9)
21 (42.0)
ASA 3 - Severe Disturb
1087 (47.7)
921 (47.1)
139 (50.2)
27 (54.0)
ASA 4 - Life Threat
56 (2.5)
49 (2.5)
6 (2.2)
1 (2.0)
ASA 5 - Moribund
2 (0.1)
0 (0.0)
1 (0.4)
1 (2.0)
None assigned
1 (0.0)
1 (0.1)
0 (0.0)
0 (0.0)
Biologic therapy (within 60 days) (%)
Cannot be determined
27 (1.3)
23 (1.3)
1 (0.4)
3 (6.5)
0.005
No
1129 (54.8)
964 (54.7)
135 (53.6)
30 (65.2)
Yes
904 (43.9)
775 (44.0)
116 (46.0)
13 (28.3)
Immunomodulator use (within 60 days) (%)
Cannot be determined
20 (1.0)
17 (1.0)
2 (0.8)
1 (2.2)
0.880
No
1839 (89.8)
1576 (90.0)
223 (89.2)
40 (87.0)
Yes
188 (9.2)
158 (9.0)
25 (10.0)
5 (10.9)
Elective surgery (%)
No
312 (22.9)
263 (22.2)
43 (30.1)
6 (17.6)
0.083
Yes
1048 (77.1)
920 (77.8)
100 (69.9)
28 (82.4)
Broad procedure category (Tier 1) (%)
TAC-EI
1095 (48.0)
919 (47.0)
156 (56.3)
20 (40.0)
0.015
RPC-IPAA
816 (35.8)
703 (36.0)
91 (32.9)
22 (44.0)
TPC-EI
370 (16.2)
332 (17.0)
30 (10.8)
8 (16.0)
Granular staged pathway (Tier 2) (%)
TAC-EI (Stage 1 Staged Colectomy)
966 (47.9)
812 (47.0)
137 (56.1)
17 (37.8)
0.002
exact (sim)
Classic 2-Stage RPC-IPAA
102 (5.1)
92 (5.3)
5 (2.0)
5 (11.1)
3-Stage Completion IPAA
616 (30.6)
523 (30.3)
78 (32.0)
15 (33.3)
1-Stage RPC-IPAA
5 (0.2)
4 (0.2)
0 (0.0)
1 (2.2)
Modified 2-Stage Completion IPAA
4 (0.2)
4 (0.2)
0 (0.0)
0 (0.0)
TPC-EI (Permanent Ostomy)
323 (16.0)
292 (16.9)
24 (9.8)
7 (15.6)
Flowchart to see how everything was further broken down:
flowchart TD
Raw["<b>Initial Dataset</b><br/>N = 8,304"] --> UCExcl["Excluded: Non-UC Diagnosis<br/>(n = 5,290)"]
Raw --> UC["<b>Ulcerative Colitis Cohort</b><br/>n = 3,014"]
UC --> CPTExcl["Excluded: Non-Study CPT Codes<br/>(n = 514)"]
UC --> A["<b>Initial ACS-NSQIP UC Cohort</b><br/>N = 2,500"]
A --> B["Excluded: Unknown / Unreported<br/>Race or Ethnicity (n = 219)"]
A --> C["<b>Primary Analytic Cohort (Tier 1)</b><br/>N = 2,281<br/><i>White: 1,954 | URM: 277 | Asian: 50</i>"]
C --> D["<b>TAC-EI</b><br/>CPT 44150, 44151, 44210<br/>n = 1,095 (48.0%)"]
C --> E["<b>RPC-IPAA</b><br/>CPT 44157, 44158, 44211,<br/>45113, 45397<br/>n = 816 (35.8%)"]
C --> F["<b>TPC-EI / Non-Restorative</b><br/>CPT 44155, 44156, 44212, 45395<br/>n = 370 (16.2%)"]
D --> D1["Excluded: Missing or 'ibd_ileost'<br/>ileostomy_formation (n = 129)"]
D --> D2["<b>Stage 1: Initial Staged Colectomy</b><br/><i>(3-Stage or Modified 2-Stage Pathway)</i><br/>TAC-EI + End Ileostomy (n = 966)"]
E --> G["Excluded: Missing or 'ibd_ileost'<br/>ileostomy_formation (n = 89)"]
E --> H["<b>Restorative IPAA Cohort (Tier 2)</b><br/>n = 727"]
H --> I["<b>Classic 2-Stage RPC-IPAA</b><br/>Primary IPAA + New Loop Ileostomy<br/>n = 102"]
H --> J["<b>3-Stage Approach (Stage 2)</b><br/>Completion IPAA + Diverting Ileostomy<br/>n = 616"]
H --> K["<b>1-Stage RPC-IPAA</b><br/>Primary IPAA, No Ileostomy<br/>n = 5"]
H --> L["<b>Modified 2-Stage (Stage 2)</b><br/>Completion IPAA, No Ileostomy<br/>n = 4"]
F --> F1["Excluded: Missing or 'ibd_ileost'<br/>ileostomy_formation (n = 47)"]
F --> F2["<b>Non-Restorative Permanent Ostomy</b><br/>TPC-EI / Completion Proctectomy<br/>n = 323"]
style Raw fill:#f4f6f9,stroke:#2c3e50,stroke-width:2px
style UC fill:#f4f6f9,stroke:#2c3e50,stroke-width:2px
style UCExcl fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
style CPTExcl fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
style A fill:#f4f6f9,stroke:#2c3e50,stroke-width:2px
style C fill:#e8f4f8,stroke:#1f618d,stroke-width:2px
style H fill:#e8f4f8,stroke:#1f618d,stroke-width:2px
style B fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
style D1 fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
style G fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
style F1 fill:#fdf2e9,stroke:#d35400,stroke-dasharray: 5 5
Figure 1: Cohort Selection and Two-Tier Surgical Staging Classification
6. Defining URM
URM will be defined as anyone of hispanic ethnicity, black or AA, american indian or alaska native, native hawaiian or other pacific islander
Nonhispanic white- not hispanic, white race
Asian- not hispanic, Asian race
White URM Asian <NA>
1954 277 50 219
7. Table 1: Demographics by Race
Manuscript-style Table 1:
Brief methods: Continuous variables were compared across racial and ethnic groups using one-way analysis of variance (ANOVA) or the Kruskal-Wallis test, while categorical variables were compared using Pearson’s chi-squared test or Fisher’s exact test (with Monte Carlo simulation across 10,000 replicates where expected cell counts were <5).
Table 1: Baseline Demographic and Clinical Characteristics Stratified by Race and Ethnicity
Characteristic
level
Overall
White
URM
Asian
p
test
n
2281
1954
277
50
Age at surgery, years (mean (SD))
42.85 (16.87)
43.21 (16.99)
40.36 (15.85)
42.49 (16.64)
0.030
Sex (%)
Female
631 (44.5)
540 (44.0)
80 (51.9)
11 (31.4)
0.049
Male
786 (55.5)
688 (56.0)
74 (48.1)
24 (68.6)
BMI, kg/m² (mean (SD))
25.42 (5.75)
25.37 (5.54)
26.27 (7.07)
22.71 (4.80)
<0.001
Diabetes mellitus (%)
Insulin
65 (2.8)
49 (2.5)
12 (4.3)
4 (8.0)
0.058
No
2140 (93.8)
1837 (94.0)
259 (93.5)
44 (88.0)
Non-Insulin
76 (3.3)
68 (3.5)
6 (2.2)
2 (4.0)
Hypertension requiring medication (%)
No
1920 (84.2)
1640 (83.9)
240 (86.6)
40 (80.0)
0.366
Yes
361 (15.8)
314 (16.1)
37 (13.4)
10 (20.0)
Current smoker (within 1 year) (%)
No
2150 (94.3)
1842 (94.3)
259 (93.5)
49 (98.0)
0.452
Yes
131 (5.7)
112 (5.7)
18 (6.5)
1 (2.0)
ASA classification (%)
ASA 1 - No Disturb
8 (0.4)
7 (0.4)
1 (0.4)
0 (0.0)
0.002
ASA 2 - Mild Disturb
1127 (49.4)
976 (49.9)
130 (46.9)
21 (42.0)
ASA 3 - Severe Disturb
1087 (47.7)
921 (47.1)
139 (50.2)
27 (54.0)
ASA 4 - Life Threat
56 (2.5)
49 (2.5)
6 (2.2)
1 (2.0)
ASA 5 - Moribund
2 (0.1)
0 (0.0)
1 (0.4)
1 (2.0)
None assigned
1 (0.0)
1 (0.1)
0 (0.0)
0 (0.0)
Biologic therapy (within 60 days) (%)
Cannot be determined
27 (1.3)
23 (1.3)
1 (0.4)
3 (6.5)
0.005
No
1129 (54.8)
964 (54.7)
135 (53.6)
30 (65.2)
Yes
904 (43.9)
775 (44.0)
116 (46.0)
13 (28.3)
Immunomodulator use (within 60 days) (%)
Cannot be determined
20 (1.0)
17 (1.0)
2 (0.8)
1 (2.2)
0.880
No
1839 (89.8)
1576 (90.0)
223 (89.2)
40 (87.0)
Yes
188 (9.2)
158 (9.0)
25 (10.0)
5 (10.9)
Elective surgery (%)
No
312 (22.9)
263 (22.2)
43 (30.1)
6 (17.6)
0.083
Yes
1048 (77.1)
920 (77.8)
100 (69.9)
28 (82.4)
Broad procedure category (Tier 1) (%)
TAC-EI
1095 (48.0)
919 (47.0)
156 (56.3)
20 (40.0)
0.015
RPC-IPAA
816 (35.8)
703 (36.0)
91 (32.9)
22 (44.0)
TPC-EI
370 (16.2)
332 (17.0)
30 (10.8)
8 (16.0)
Granular staged pathway (Tier 2) (%)
TAC-EI (Stage 1 Staged Colectomy)
966 (47.9)
812 (47.0)
137 (56.1)
17 (37.8)
0.002
exact (sim)
Classic 2-Stage RPC-IPAA
102 (5.1)
92 (5.3)
5 (2.0)
5 (11.1)
3-Stage Completion IPAA
616 (30.6)
523 (30.3)
78 (32.0)
15 (33.3)
1-Stage RPC-IPAA
5 (0.2)
4 (0.2)
0 (0.0)
1 (2.2)
Modified 2-Stage Completion IPAA
4 (0.2)
4 (0.2)
0 (0.0)
0 (0.0)
TPC-EI (Permanent Ostomy)
323 (16.0)
292 (16.9)
24 (9.8)
7 (15.6)
multivariable regression model for definitive surgery (TAC EI vs TPC EI/RPC IPAA)
Table 2: Multivariable Logistic Regression for Initial Staged Colectomy (TAC-EI) vs. Definitive Proctocolectomy
Characteristic
OR
95% CI
p-value
Race and ethnicity
White
—
—
URM
1.62
1.02, 2.56
0.040
Asian
0.56
0.22, 1.33
0.2
Age at surgery, years
0.99
0.98, 1.00
0.017
Sex
Female
—
—
Male
1.07
0.81, 1.43
0.6
BMI, kg/m²
0.98
0.96, 1.01
0.2
Diabetes mellitus
Insulin
—
—
No
0.65
0.30, 1.44
0.3
Non-Insulin
0.97
0.33, 2.84
>0.9
Hypertension requiring medication
No
—
—
Yes
1.11
0.70, 1.75
0.7
Current smoker (within 1 year)
No
—
—
Yes
1.52
0.83, 2.76
0.2
ASA classification
ASA 1-2
—
—
ASA 3
1.41
1.04, 1.91
0.028
ASA 4-5
4.72
1.37, 19.6
0.020
Biologic therapy (within 60 days)
Cannot be determined
—
—
No
0.04
0.00, 0.19
<0.001
Yes
0.21
0.02, 1.08
0.094
Immunomodulator use (within 60 days)
Cannot be determined
—
—
No
5.49
1.20, 32.7
0.041
Yes
14.2
2.89, 89.4
0.002
Elective surgery
No
—
—
Yes
0.08
0.05, 0.13
<0.001
Abbreviations: CI = Confidence Interval, OR = Odds Ratio
8. Unadjusted Outcomes for Postoperative Complications
Table 3: Unadjusted 30-Day Postoperative Outcomes Stratified by Race and Ethnicity (N = 2,281)
30-Day Outcome
Overall N = 2,2811
White N = 1,9541
URM N = 2771
Asian N = 501
p-value2
Composite 30-day complication (any)
444 (19.5%)
373 (19.1%)
62 (22.4%)
9 (18.0%)
0.4
Hospital length of stay, days
5.0 (3.0, 10.0)
5.0 (3.0, 9.0)
7.0 (4.0, 13.0)
5.0 (4.0, 8.0)
<0.001
Unknown
22
16
6
0
30-day unplanned readmission
366 (16.0%)
310 (15.9%)
47 (17.0%)
9 (18.0%)
0.8
Anastomotic leak
44 (1.9%)
38 (1.9%)
6 (2.2%)
0 (0.0%)
0.9
Unplanned return to OR
122 (5.3%)
106 (5.4%)
15 (5.4%)
1 (2.0%)
0.7
Bleeding requiring transfusion
131 (5.7%)
111 (5.7%)
17 (6.1%)
3 (6.0%)
0.9
30-day mortality
8 (0.4%)
8 (0.4%)
0 (0.0%)
0 (0.0%)
0.7
Superficial incisional SSI
77 (3.4%)
71 (3.6%)
5 (1.8%)
1 (2.0%)
0.3
Deep incisional SSI
10 (0.4%)
7 (0.4%)
2 (0.7%)
1 (2.0%)
0.10
Wound disruption / dehiscence
10 (0.4%)
9 (0.5%)
1 (0.4%)
0 (0.0%)
>0.9
Pneumonia
33 (1.4%)
26 (1.3%)
6 (2.2%)
1 (2.0%)
0.3
Unplanned intubation
16 (0.7%)
14 (0.7%)
2 (0.7%)
0 (0.0%)
>0.9
Pulmonary embolism
19 (0.8%)
18 (0.9%)
1 (0.4%)
0 (0.0%)
0.7
Ventilator > 48 hours
17 (0.7%)
14 (0.7%)
3 (1.1%)
0 (0.0%)
0.6
Progressive renal insufficiency
7 (0.3%)
7 (0.4%)
0 (0.0%)
0 (0.0%)
>0.9
Acute renal failure
3 (0.1%)
3 (0.2%)
0 (0.0%)
0 (0.0%)
>0.9
Urinary tract infection
30 (1.3%)
25 (1.3%)
5 (1.8%)
0 (0.0%)
0.7
Stroke / CVA
0
2,281 (100%)
1,954 (100%)
277 (100%)
50 (100%)
Myocardial infarction
0
2,281 (100%)
1,954 (100%)
277 (100%)
50 (100%)
Sepsis
92 (4.0%)
73 (3.7%)
16 (5.8%)
3 (6.0%)
0.2
Septic shock
32 (1.4%)
26 (1.3%)
6 (2.2%)
0 (0.0%)
0.4
DVT requiring therapy
49 (2.1%)
44 (2.3%)
3 (1.1%)
2 (4.0%)
0.2
1n (%); Median (Q1, Q3)
2Fisher's Exact Test for Count Data with simulated p-value (based on 10000 replicates); Kruskal-Wallis rank sum test; NA
9. Multivariable Regression Model for Postoperative Complications
Characteristic
OR
95% CI
p-value
Race and ethnicity
White
—
—
URM
1.30
0.84, 2.01
0.2
Asian
0.82
0.32, 2.11
0.7
Broad procedure category
TAC-EI
—
—
RPC-IPAA
0.99
0.66, 1.48
>0.9
TPC-EI
1.22
0.78, 1.89
0.4
Age at surgery (per year)
1.01
1.00, 1.02
0.2
Sex
Female
—
—
Male
1.00
0.75, 1.33
>0.9
BMI (per kg/m²)
1.01
0.99, 1.04
0.3
ASA classification
ASA 1-2
—
—
ASA 3
1.67
1.23, 2.28
0.001
ASA 4-5
3.82
1.65, 8.82
0.002
Elective surgery
No
—
—
Yes
0.46
0.32, 0.66
<0.001
Diabetes mellitus
No
—
—
Insulin
1.71
0.85, 3.46
0.13
Non-Insulin
0.79
0.35, 1.79
0.6
Hypertension requiring medication
No
—
—
Yes
1.13
0.75, 1.72
0.6
Current smoker (within 1 year)
No
—
—
Yes
0.61
0.31, 1.18
0.14
Biologic therapy (within 60 days)
No
—
—
Cannot be determined
1.86
0.47, 7.30
0.4
Yes
1.08
0.77, 1.50
0.7
Immunomodulator use (within 60 days)
No
—
—
Cannot be determined
0.92
0.25, 3.38
>0.9
Yes
0.69
0.41, 1.15
0.2
Abbreviations: CI = Confidence Interval, OR = Odds Ratio